Virtual-Rx bridges the gap between discovery and therapy by establishing drug discovery programs as independently held corporations (LLC’s) built on a common drug discovery infrastructure and using a virtual, just-in-time operations ecosystem.
Each corporation leverages the Virtual-Rx ecosystem, comprised of a network of trusted CRO partners and an advanced scientific, business process and informatics platform developed by the Virtual-Rx team. This approach results in drug discovery programs that are lean, capable and readily adaptable to address the widening innovation gap in the development of new therapies. At Virtual-Rx we believe that, when executed effectively, the virtual drug discovery model will transform the way the new drugs are discovered and developed, speeding new therapies to the patients who need them.
Company Details
- Founded
- -
- Address
- The Widening Innovation Gap In The Development Of New Therapies. At Virtual-Rx We Believe That
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- virtual-rx.com
Virtual-Rx, Inc Questions
Virtual-Rx, Inc's website is virtual-rx.com
Virtual-Rx, Inc's LinkedIn profile is https://www.linkedin.com/company/virtual-rx-inc
Virtual-Rx, Inc's industry is
Biotechnology Research
Virtual-Rx, Inc's top competitors are
Strategic Preclinical Product Development,
Virtual Discovery, Inc,
Bienta,
Mag-Lab,
Biomedha,
Protac Scientific-Drug Discovery Pro,
Avastus Preclinical Services Llc,
Accelero Biostructures,
Translational Biotech Solutions, Llc,
Lifetein.com.
Virtual-Rx, Inc's categories are Biotechnology Research
Virtual-Rx, Inc's founding year is 2013
